Clinical Trial Update: Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients [Phase 2]

View source ↗

Summary

Phase 2 trial investigating autologous bone marrow mesenchymal stem cells with intensive atorvastatin for myocardial infarction; status not yet known.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Autologous bone marrow mesenchymal stem cells (mesenchymal stem cells)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Yuejin Yang | Conditions: Myocardial Infarction, Stem Cell Transplantation | Phase 2 | Status: UNKNOWN